Overview
Financials
Revenue history (in k)
Filing timeliness
No financial statement for 2025 – the filing deadline has passed. 5 of 6 financial statements were filed late (the longest delay 770 days for 2020), 1 not filed.
- 2025not filed
- 202413/04/2026
- 202330/04/2025
- 202206/02/2024
- 202127/06/2023
- 202024/11/2023
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2024.
Results vs industry
Industry
Trademarks
Superinvest currently holds no active trademarks with the Polish Patent Office. 1 mark has expired or was not registered. The first mark was filed in 2017.
| Mark | Protected until | |
|---|---|---|
| Biolane Pharm | – |
Authorized Representatives
Manner of representation
In the case of a one-person management board, the company is represented independently by the President of the Management Board, whereas in the case of a multi-member management board, two members of the management board jointly or one member of the management board jointly with a commercial proxy are authorised to make declarations and sign on behalf of the company.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Sylwia Ariana Chojnacka Gordonage 55 | 245 | $6,618.04 | 49% |
Grzegorz Jerzy Gordonage 55 | 245 | $6,618.04 | 49% |
Others | 10 | $270.12 | 2% |
Grzegorz Jerzy Gordon and Sylwia Ariana Chojnacka Gordon hold a combined 98% – the ownership structure indicates family control.
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2015-03-26.
66 2030 0045 1110 0000 0404 4690
45 2030 0045 1110 0000 0404 4680
54 1160 2202 0000 0006 2013 2472
Debt
No entries in the National Debtors Register (KRZ).
MSiG notices
| Publication date | Event | |
|---|---|---|
| Jun 23, 2022 | Dissolution without liquidation opened | |
| Mar 21, 2017 | Merger plan |
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jul 31, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $0$0 | Polski Fundusz Rozwoju S.A. |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Farmjugsp. z o.o. | $14,506,326.49 | farmjug.pl | ||
| MybestpharmS.A. | $10,884,130.91 | mybestpharm.pl | ||
| Fragalsp. z o.o. | $5,374,285.81 | aptekafragal.pl | ||
| Modrzewscysp. j. | $5,602,358.99 | aptekacentrum.lublin.pl | ||
| Ms-Pharmsp. z o.o. + limited partnership | $4,619,501.46 | mspharm.pl | ||
| Farmjug Agsp. z o.o. | $4,213,734.86 | farmjug.pl | ||
| MagmaxS.A. | $4,200,912.15 | magmaxsa.pl | ||
| Adpharmasp. z o.o. | $4,026,799.19 | adamed.com | ||
| Alfa Pharm - Małgorzata Janusik, Jarosław Janusiksp. j. | $3,414,382.70 | aptekazielona.com.pl | ||
| Twoja Tania Apteka Farmarsp. z o.o. | $440,843.57 | domlekow.pl |
FAQ
Last updated: 2026-04-13